CIT Therapeutics and IFLI Launch Collaboration for Innovative Cancer Treatments CIT Therapeutics collaborates with IFLI to advance innovative therapies for follicular lymphoma, securing $2.5 million for clinical development.

CIT Therapeutics and IFLI Launch Collaboration for Innovative Cancer Treatments #United_States #cancer_therapies #Diamond_Bar #IFLI #CIT_Therapeutics